02329.HK
Glory Health Industry Limited
HKSE · Real Estate · Real Estate - Development · CN
HKD 0.10
+1.98%Year over year
Reported trailing growth
- Revenue
- -41.6%
- EBITDA
- +47.5%
- EBIT
- +41.7%
- EPS
- —
- Free cash flow
- -15.1%
- Operating cash flow
- -32.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -35.8%
- EBITDA
- —
- EBIT
- —
- Net income
- -46.9%
- EPS
- -46.4%
- Free cash flow
- -66.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025